Compare NTST & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTST | STAA |
|---|---|---|
| Founded | 2019 | 1982 |
| Country | United States | United States |
| Employees | N/A | 1211 |
| Industry | Real Estate Investment Trusts | Ophthalmic Goods |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2020 | N/A |
| Metric | NTST | STAA |
|---|---|---|
| Price | $17.58 | $24.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | $20.27 | ★ $24.56 |
| AVG Volume (30 Days) | 1.0M | ★ 1.2M |
| Earning Date | 10-27-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $186,604,000.00 | ★ $230,591,000.00 |
| Revenue This Year | $17.52 | N/A |
| Revenue Next Year | $10.04 | $22.61 |
| P/E Ratio | $8,007.70 | ★ N/A |
| Revenue Growth | ★ 19.54 | N/A |
| 52 Week Low | $13.42 | $13.50 |
| 52 Week High | $19.64 | $30.81 |
| Indicator | NTST | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 42.10 |
| Support Level | $17.25 | $23.30 |
| Resistance Level | $18.08 | $25.35 |
| Average True Range (ATR) | 0.26 | 1.18 |
| MACD | -0.01 | -0.23 |
| Stochastic Oscillator | 31.36 | 20.86 |
Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.